India gets first state-of-the-art homoeopathy
research lab
The laboratory, established
at a cost of 8 crore, is the only one in
India for conducting basic and fundamental research in homoeopathy for viral
diseases such as influenza, Japanese encephalitis, dengue, chikunguniya and
swine flu.
Union minister of state for
Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Shripad
Yesso Naik, inaugurated the state-of-the art laboratory at Kolkata’s Dr Anjali
Chatterjee Regional Research Institute for Homoeopathy (RRIH).
This
laboratory has been established to develop new drugs and technologies in
homoeopathy to combat emerging challenges of viral diseases
The laboratory is recognized
by the Calcutta University to undertake research work of the PhD students in
the field of homoeopathy.
The
laboratory, established at a cost of 8
crore, is the only one in India for conducting basic and fundamental research
in homoeopathy for viral diseases such as influenza, Japanese
encephalitis, dengue, chikunguniya and swine flu. The laboratory will also be
used to create new drugs and technologies in treating these viral diseases.
West
Bengal’s National Institute of Homoeopathy (NIH) and RRIH are expected to
actively collaborate to impart practical training to the students and research
scholars in virus research, both in laboratory and in the field.
Howrah-based
Centre of Excellence in Fundamental Research in Homoeopathy will also undertake
fundamental research studies in homoeopathy with an interdisciplinary approach.
This
institute has undertaken several clinical research studies such as autism,
psoriasis, vitiligo, breast cancer, hypertension, migraine etc. along with
proving of new drugs in homoeopathy with their clinical validations
About 400 patients are
being treated daily through the out patient department (OPD) services and AYUSH
outreach services are being provided also in villages.
Government
of India is doing everything possible to promote research in various departments
of homoeopathy— clinical research, drug standardization and basic research, and
encourages new researchers to make India the leader in research arena of
homoeopathy